Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Alpa Laboratories Ltd

ALPA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.67

▼ -2.40%

Market Cap $14.17M · Vol 34.94K

Key Metrics

P/E Ratio

8.93

FWD: N/A

Market Cap

$14.17M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

40.20

Momentum

Beta

1.80

vs Market

52W High

$1.06

41.82% below

52W Low

$0.48

37.83% above

Volume

34.94K

Avg 18.97K

P/B

0.52

Price-to-book

ROE

N/A

Return on equity

Free Float

42.71%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Alpa Laboratories Ltd (ALPA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ALPA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.61%

-10.31%

-5.76%

-5.00%

YTD

-17.27%

-32.10%

-25.57%

+18.91%

Financials & Valuation

TTM · Annual

Total Revenue	$11.32M
Net Income	$1.61M
Revenue Growth (YoY)	+25.22%
Gross Margin	27.80%
Operating Margin	1.13%
Net Profit Margin	14.19%
ROE	N/A
ROA · ROIC	7.19% · 8.46%

P/E Ratio	8.93
Forward P/E (FY1)	N/A
PEG Ratio	-0.28
P/S	0.92
P/B	0.52
P/FCF	11.52
EPS Growth	N/A
Outstanding Shares	21.04M

Technical Indicators

50-Day SMA	$0.71
200-Day SMA	$0.74
RSI (14)	40.20
Beta	1.80
52-Week High	$1.06
52-Week Low	$0.48

Volume Today	34.94K
Avg Daily Volume (30D)	18.97K
Relative Volume	1.84x
Volatility (10D)	28.43
Volatility (30D)	25.31
Free Float	42.71%

Analyst Consensus

N/A

Current Price $0.67

Mean Target N/A

52W Low$0.48 52W High$1.06

Current

Target

$0.48 $1.06

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SS80P9

ISININE385I01010

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.